Measurement of hypoxia in vivo using a 2-nitroimidazole (NITP).
Hodgkiss
R J
RJ
Gray Laboratory Cancer Research Trust, Mount Vernon Hospital, Northwood, Middlesex, England.
Webster
L
L
Wilson
G D
GD
D000230:Adenocarcinoma / Q000378:metabolism* / Q000473:pathology; D000818:Animals; D015687:Cell Hypoxia; D005260:Female; D005434:Flow Cytometry / Q000379:methods; D019084:Fluorescent Antibody Technique, Indirect; D008325:Mammary Neoplasms, Experimental / Q000378:metabolism* / Q000473:pathology; D051379:Mice; D009593:Nitroimidazoles / Q000493:pharmacokinetics; D010100:Oxygen / Q000032:analysis*; D012119:Respiration; D012513:Sarcoma, Experimental / Q000378:metabolism* / Q000473:pathology; D013806:Theophylline / Q000031:analogs & derivatives* / Q000493:pharmacokinetics
D009593:Nitroimidazoles; C075173:7-(4'-(2-nitroimidazole-1-yl)butyl)theophylline; D013806:Theophylline; D010100:Oxygen